Literature DB >> 30955899

Glaucoma progression analysis by Spectral-Domain Optical Coherence Tomography (SD-OCT).

J-P Renard1, J-R Fénolland2, J-M Giraud2.   

Abstract

Spectral domain optical coherence tomography (SD-OCT) provides an objective quantification of the lesions of various target tissue structures in glaucoma, with unprecedented resolution, which has now demonstrated its interest in controlling the progression of glaucomatous neuropathy, from early stages to late stages. A certain number of well-established proofs state that a progressive modification in OCT is a common predictor of functional loss, and that patients with rapid OCT changes have an increased risk of developing glaucomatous scotoma. Follow-up of the progression goes through three stages. It consists first of all in detecting the evolution of damage to the retinal nerve fiber layer (RNFL), then that of the macular ganglion cell complex (GCC), in order to better define this progression of the damage to the target structures and, thirdly, to complete its analysis by integrating it with the analysis of the functional impairment. We note today that there is a greater risk of developing a future functional deficit of the visual field in subjects with a RNFL loss slope greater than -1/year, for all clinical stages of glaucoma. The characteristics of GCC progression are much better specified. Often earlier than that of the progress of the thinning of the RNFL and much faster in the subjects considered as "progressors", its cartography is better defined, with a particular interest for the follow-up of diversion maps and "wide field" acquisitions offering better visibility of deficits and their progression. To date, a certain number of suspicious indicators of short-term progress can be retained, highlighting the essential precaution of having two or more basic measures and a confirmation of the change on at least one new OCT acquisition. Finally, if the interpretation of the progression must always be based on clinical examination data, and the macula in particular, it remains crucial to confront the progression of the RNFL with that of the GCC and with that of the visual field.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glaucoma; Macular ganglion cell complex; Optical coherence tomography; Progression; Retinal nerve fibers

Year:  2019        PMID: 30955899     DOI: 10.1016/j.jfo.2019.03.001

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  4 in total

1.  Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma.

Authors:  Asena Keles Sahin; Hasan Burhanettin Kapti; Aslihan Uzun
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

Review 2.  Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases.

Authors:  Ming Yang; Yanling Wang
Journal:  J Ophthalmol       Date:  2022-05-20       Impact factor: 1.974

3.  Biological Correlations and Confounders for Quantification of Retinal Ganglion Cells by Optical Coherence Tomography Based on Studies of Outbred Mice.

Authors:  Adam Hedberg-Buenz; Kacie J Meyer; Carly J van der Heide; Wenxiang Deng; Kyungmoo Lee; Dana A Soukup; Monica Kettelson; Danielle Pellack; Hannah Mercer; Kai Wang; Mona K Garvin; Michael D Abramoff; Michael G Anderson
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

4.  Impact of Epiretinal Membrane on Optical Coherence Tomography Tools Used for Monitoring Glaucoma.

Authors:  Marco Rocco Pastore; Riccardo Merli; Carmen Dell'Aquila; Lorenzo Belfanti; Marco Franzon; Gabriella Cirigliano; Chiara De Giacinto; Rosa Giglio; Daniele Tognetto
Journal:  Diagnostics (Basel)       Date:  2021-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.